MCRB SERES THERAPEUTICS INC Delisting Actions 8-K Filing 2024 - Delisting Notice Seres Therapeutics received a letter from Nasdaq stating that its common stock has closed below the minimum bid price requirement for continued inclusion on the Nasdaq Global Select Market.Get access to all SEC 8-K filings of the SERES THERAPEUTICS INC